Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Graalum – page 8

90 clinical trials in Graalum, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Graalum at a glance
90
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

90 trials in Graalum

Open in trial search

COVID-19

Not recruiting

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Institut National De La Sante Et De La Recherche Medicale

Malignant melanoma

Not recruiting

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Labour induction

Not recruiting

Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Oslo University Hospital HF

Drug dependence

Not recruiting

Study of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Diazepam
  • Sponsor:Helse Bergen HF

Metastatic neoplasm+1

Not recruiting

Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Oslo University Hospital HF

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Graalum

What the registry says about research in the country

01 Diseases of the Digestive System

Clinical research in this area focuses on digestive system diseases, especially low anterior resection syndrome after surgery for rectal cancer. The trials in Grålum aim to better understand symptom relief and improve quality of life for people living with ongoing bowel problems.

  • Evaluating a treatment intended to reduce the burden of LARS symptoms
  • Studying symptom control after rectal cancer surgery

This work supports better management of postoperative bowel dysfunction and patient comfort.

02 Diseases of the Nervous System

Research in nervous system diseases is centered on acute ischemic stroke, with attention to whether early treatment can improve neurological recovery. The goal is to compare treatment approaches and strengthen care for patients facing urgent stroke events.

  • Assessing early neurological improvement after stroke treatment
  • Comparing outcomes in patients with acute ischemic stroke

These trials are designed to refine stroke treatment and support faster recovery.

03 Viral Diseases and Respiratory Infections

A major focus in virus diseases is viral respiratory tract infection, where investigators are testing whether stopping antibiotics is safe when a respiratory virus has been confirmed. This research helps guide more appropriate treatment and reduce unnecessary antibiotic use.

  • Evaluating antibiotic discontinuation in viral respiratory illness
  • Testing treatment decisions for patients with positive respiratory virus samples

The study supports smarter infection management and better antibiotic stewardship.

04 Pathological Conditions, Signs and Symptoms

Research in pathological conditions, signs and symptoms connects several of the local studies by focusing on how symptoms change with treatment. In this small but active research setting, the emphasis is on practical benefits for patients rather than broad experimental complexity.

  • Measuring symptom burden as a key outcome
  • Tracking improvement in everyday health problems

The trials aim to show whether current approaches can ease symptoms more effectively and safely.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.